Gene-Edited Banana Startup Secures $105 Million in New Round
6 Articles
6 Articles
Tropic raises $105M to scale gene-edited bananas
The Norwich-based agbiotech company launched the first new commercial banana varieties in more than 75 years in 2025. Now it has to build enough supply to meet demand. The world’s favourite fruit is in serious trouble. Panama Disease Tropical Race 4, a fungal pathogen that travels in soil and water and leaves no cure in […] This story continues at The Next Web
UK biotech firm raises US$105 million to expand gene-edited bananas
Tropic, a biotechnology company based in Norwich, UK, has raised US$105 million in a Series C funding round to expand the commercial production of its banana varieties and advance the development of other crops. The round was co-led by the Forbion Bioeconomy Fund and Corteva through its Corteva Catalyst…
Norwich gene editing group scores £80m round
Tropic, a Norwich-based agtech specialising in gene-edited tropical crops, has secured a $105m (£79.2m) Series C funding round. The company, which uses a proprietary platform to develop improved crops that are resistant to disease with higher yields, is planning the global commercial scale up of its crop portfolios following the sizeable round. Currently Tropic’s crop portfolio is focused on bananas and rice, which it genetically engineers to me…
Tropic bags $105m to scale gene-edited bananas, deploy TR4 resistant bananas in 2027
UK-based plant biotech company Tropic has raised a $105 million Series C round to support the rollout of non-browning bananas and bananas with extended shelf-life—innovations it says are opening up the cut fruit market, cutting food waste, unlocking new export markets, and reducing shipping costs. Separately, it has advanced plans to establish a mother plantation to support commercial deployment of Cavendish bananas resistant to the devastatin…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium



